Series date: 
04/15/2021 - 7:00am to 12/30/2021 - 8:00am

Mayo Clinic is committed to taking care of learners and staff during the COVID-19 pandemic.  Therefore, please be cognizant of, and abide by any current guidelines regarding in-person gatherings, while following Mayo Clinic recommendations and CPD’s COVID-19 resources page.
 

Course Description:
A weekly clinical case conference interfacing the disciplines of neurosurgery, neuro-oncology, radiation oncology, pathology, and other related specialties (e.g. epilepsy) in which all patients presenting with tumors and related lesions are discussed for multi-modality cancer care of the central and peripheral nervous system. Conference discussions have a direct impact on subsequent patient care decisions and activities.
 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


 

Credit Statement(s): 
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
 

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.


Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Leland Hu, MD – Consultant: Imaging Biometrics, LLC (medical advisory board); Stock Shareholder (self-managed): MMV Know How with Imaging Biometrics, LLC; Other: Precision Oncology Insights (co-founder)
Maziyar Kalani, MD – Consultant: CarboFix, NuVasive, Medtronic
 

No relevant financial relationship(s) with industry:
Bernard Bendok MD, Richard Zimmerman MD.; Alyx Porter MD; Maciej Mrugala MD, PhD; Sujay Vora, MD; Kliment Donev, MD; Kristin Swanson, PhD; Marie Acierno, MD; Chandan Krishna, MD; Carl Ariete, RN; Vanesa Vanderhye, RN; CCRN, SCRN; Alyssa Yong; Katie Harris; Cassaundra Buehrle

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.
 
Support location: 
Arizona